Baseline characteristics of excluded patients because of missing insulin data or being treated with insulin are comparable with those who went into final analysis generally, except for the previous stroke/TIA occurrence, smoking status, and admission fasting glucose. This evidence concerns the gene INS and transient ischemic attack.